T
Tristel
OrganizationHeard in 2 episodes across 1 show since Jun 2024
A UK healthcare company developing infection-prevention and decontamination products, particularly for medical instruments and clinical environments.
Episodes
2
across 1 show
First heard
Jun 2024
Expert statements
3
2 negative
What experts have said about Tristel
3 statements · 2 negative · 1 mixed
Tristel’s valuation is demanding at roughly thirty times forecast earnings.
“The shares are trading at, I don't know, about 30-odd times forecast earnings. So it's quite a punchy rating.”
Open the episode · IC028 UK investors Insights Covering Alphabet, Nestle, Unilever, Tristel, Nichols, Nexteq, LBG Media, Ryanair, EasyJet & FRP Advisory Group.Listen at 24:33
Tristel’s demanding valuation depends on continued US growth.
“It just looks really demanding to us, but potentially it's justified. But it all depends on that US growth.”
Open the episode · IC028 UK investors Insights Covering Alphabet, Nestle, Unilever, Tristel, Nichols, Nexteq, LBG Media, Ryanair, EasyJet & FRP Advisory Group.Listen at 26:18
Tristel shares have a high valuation.
“It's very highly rated.”
Open the episode · IC023 Investor Insights: Private Equity Trends, Contrasting Founders, Good Results & Investment IdeasListen at 24:01
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring Tristel, newest first
